A Case Report of Systemic Type Juvenile Idiopathic Arthritis with Night Fever

야간 발열을 동반하는 전신형(Systemic type) 소아기 류마티스 관절염(Juvenile Idiopathic Arthritis; JIA) 환아 증례보고

  • Received : 2010.11.26
  • Accepted : 2010.12.16
  • Published : 2010.12.31

Abstract

Objectives: This study is to report a case that has an effective result to systemic type juvenile idiopathic arthritis patient with an oriental medicine treatment. Methods: We treated the patient with an oriental medicine and tapered down with the western medicine. We followed up the laboratory blood tests every two or three months and through telephone at least six days in a week. Results: The symptoms of systemic type juvenile idiopathic arthritis were vanished and the patient maintains his condition with oriental medicine treatment after discontinued all Disease-Modifying Antirheumatic Drugs(DMARDs). His ESR, CRP levels and other blood test results were back to normal range. Now he is in clinical remission status. Conclusions: According to the result, the oriental medicine treatment is considered to be effective on the systemic juvenile idiopathic arthritis and further studies will be needed with more cases.

Keywords

References

  1. 한윤수, 김중곤. 소아기 류마티스 관절염에 대한 연구. 소아과. 1995;38(3):387.
  2. Philip J. Hashkes, Ronald M. Laxer. Medical Treatment of Juvenile Idiopathic Arthritis. JAMA. 2005;294(13): 1671-84. https://doi.org/10.1001/jama.294.13.1671
  3. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of Juvenile Idiopathic Arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-2.
  4. 임상류마티스학 편찬위원회. 임상류마티스학. 제1판. 서울:도서출판 한국의학사. 2006:292-309, 749.
  5. 한방재활의학과학회. 한방재활의학. 서울:군자출판사. 2005:78-99.
  6. Woo P. The cytokine network in juvenile chronic arthritis. Ann Med. 1997;29:145-7. https://doi.org/10.3109/07853899709113701
  7. De Benedetti F, Massa M, Pignatti P, et al. Serum soluble interleukin 6(IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest. 1994;93:2114-9. https://doi.org/10.1172/JCI117206
  8. 신재일, 김동수, 이수곤, 김현우. 소아기 류마티스 관절염의 경과 및 예후 인자. 대한류마티스학회지. 2003;10(4):374-93.
  9. D.A.Kietz, P.H.Pepmueller,TLMoore.Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period. Ann Rheum Dis. 2002;61:171-3. https://doi.org/10.1136/ard.61.2.171
  10. Lahdenne P, Vahasalo P, Honkanen V. Infkiximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis. 2003;62:245-7. https://doi.org/10.1136/ard.62.3.245
  11. 엔브렐25밀리그람프리필드주(에타너셉트,유전자재조합) 제품정보 상세보기. 2010년 10월 27일. at:http://ezdrug.kfda.go.kr/kfda2cmd=CCBAA02Q1&pageNo=1&itemName=엔브렐.
  12. 유창길, 이윤주. 항류마티스제(DMARDs)와 비스테로이드성 소염진통제(NSAIDs)에 반응하지 않는 다수관절형 소아기 류마티스 관절염 환아 증례 보고. 대한한방소아과학회지. 2010;24(1):61.
  13. 한주원, 송영일, 윤일지, 오민석. 祛濕複合方이 류마토이드 관절염에 미치는 영향. 한방재활의학과학회지. 2006;16(3):2.
  14. 허준. 동의보감. 서울:법인문화사. 1999:409-10.
  15. 시수도명. 임상응용 한방처방해설. 서울:의방출판사. 2008:405.
  16. 장중경. 상한론정해. 서울:경희대학교출판국. 1996: 176-86.
  17. 허준. 동의보감. 서울:동의보감출판사. 2005:1243.